Referral of Patients with Cancer for Participation in Randomized Clinical Trials: Ethical Considerations
Randomized-Blocks Design
Saddlepoint $$p$$ p -values and confidence intervals for the class of linear rank tests for censored data under generalized randomized block design
Randomized Block Design
Randomized Block Designs: Nominal Data
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial
Molecular design, synthesis and properties of block and graft copolymers containing polyoxyethylene segments
Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial
Randomized Complete Blocks Design
Randomized Complete Block Design
